Harbor Investment Advisory’s Amedisys AMED Stock Holding History

Harbor Investment Advisory’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9	Closed	-$2K	–	1128
2020 Q2	$2K	Buy	+9	New	+$1.68K	﹤0.01%	970

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harbor Investment Advisory's AMED Position: Q3 2020 in Review

Harbor Investment Advisory sold out of Amedisys (AMED) in Q3 2020, closing a stake of 9 shares — an estimated $2K sold.

Harbor Investment Advisory first reported a position in AMED in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

Harbor Investment Advisory reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
Harbor Investment Advisory sold 9 Amedisys shares in Q3 2020, an estimated $2K.
Harbor Investment Advisory first reported a position in Amedisys in Q2 2020 and held it in 1 quarter.
Harbor Investment Advisory's Amedisys position peaked at $2K in Q2 2020.
397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Harbor Investment Advisory's 13F filing for Q3 2020, filed 23 Oct 2020.